Transcatheter Aortic Heart Valve Devices Market

10 Pages | 5 Exhibits | Forecasts Through 2026

Order individually or subscribe to Medtech Pro and get a complete intel platform.

market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now
Talk to Sales

Overview

This report from Life Science Intelligence provides an analysis of the global market for transcatheter devices for the repair and/or replacement of the aortic valve. This thriving medtech market is anticipated to see strong growth, which is largely being driven by the improved access to larger subsets of patients via clinical studies that show the benefit of these technologies in lower risk patients. Epidemiological factors, chiefly the increasing prevalence of heart valve disease, is also increasing the outlook of the TAVI/TAVR devices market.

This market snapshot is intended to provide a high-level overview of the global TAVI/TAVR market, with key insights into:

  • Unit volumes from 2020 to 2026
  • Market forecasts from 2020 to 2026
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Abbott

Boston Scientific

Edwards Lifesciences

Foldax

JenaValve Technologies

LivaNova

Medtronic

Pi-Cardia

Venus Medtech

Our Clients